Multimodality treatment for locally advanced renal cancer
Multiple antitumor therapy in patients with locally advanced renal cancer leads to a 2.3-fold reduction in the incidence of recurrences during 2 years, as compared to a control group and to a 1.7-fold increase in 5-year survival rates.Magnetotherapy used as part of multimodality treatment for locall...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
ABV-press
2020-02-01
|
Series: | Onkourologiâ |
Online Access: | https://oncourology.abvpress.ru/oncur/article/view/1081 |